Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses
- PMID: 36883679
- DOI: 10.1111/jvp.13122
Concentrations, pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites following oral administration to horses
Abstract
The metabolism and pharmacokinetics of intravenous (i.v.) morphine in the horse have been described; however, administration of therapeutic doses has also been associated with neuroexcitation and adverse gastrointestinal effects. In this study, we hypothesized that oral administration would lead to comparable concentrations of morphine and its presumed active metabolite, morphine 6-glucuronide (M6G) without the adverse effects associated with i.v. administration. Eight horses were administered a single i.v. dose of 0.2 mg/kg morphine and oral doses of 0.2, 0.6, and 0.8 mg/kg of morphine in a four-way balanced crossover design, with a 2-week washout period between doses. Concentrations of morphine and metabolites were determined, and pharmacokinetic parameters determined. Physiologic and behavioral outcomes including the number of steps taken, changes in heart rate, and gastrointestinal borborygmi were assessed. Oral administration of morphine resulted in higher concentrations of morphine metabolites, including M6G (Cmax : 11.6-37.8 ng/mL (0.6 mg/kg); 15.8-42.6 ng/mL (0.8 mg/kg)), compared with i.v. Bioavailability was 36.5%, 27.6% and 28.0% for 0.2, 0.6 and 0.8 mg/kg, respectively. Behavioral and physiologic changes were noted in all groups but were less prominent with oral compared with i.v. administration. Results of the current study are encouraging for further study, specifically anti-nociceptive effects of morphine following oral administration.
Keywords: horse; morphine; opioid; oral; pharmacokinetics.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- Baldo, B. A., & Pham, N. H. (2012). Histamine-releasing and allergenic properties of opioid analgesic drugs: Resolving the two. Anaesthesia and Intensive Care, 40(2), 216-235. https://doi.org/10.1177/0310057X1204000204
-
- Bartlett, S. E., Cramond, T., & Smith, M. T. (1994). The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences, 54(10), 687-694. https://doi.org/10.1016/0024-3205(94)00552-4
-
- Bennett, R. C., & Steffey, E. P. (2002). Use of opioids for pain and anesthetic management in horses. The Veterinary Clinics of North America. Equine Practice, 18(1), 47-60. https://doi.org/10.1016/s0749-0739(02)00011-1
-
- Bowsher, D. (1993). Paradoxical pain. BMJ (Clinical Research Ed.), 306(6876), 473-474. https://doi.org/10.1136/bmj.306.6876.473
-
- Combie, J., Shults, T., Nugent, E. C., Dougherty, J., & Tobin, T. (1981). Pharmacology of narcotic analgesics in the horse: Selective blockade of narcotic-induced locomotor activity. American Journal of Veterinary Research, 42(5), 716-721.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources